Literature DB >> 1546191

Combined radiotherapy and surgery: local control and complications in early carcinoma of the uterine cervix--the Villejuif experience, 1975-1984.

A L Gerbaulet1, I H Kunkler, G R Kerr, C Haie, G Michel, M Prade, C Lhomme, M Masselot, M Albano, A Dutreix.   

Abstract

From January 1975 to December 1984, 441 patients were treated by combined radiotherapy and surgery at the Institut Gustave Roussy (IGR) for Stage IB (288) and II (proximal) (103) carcinoma of the uterine cervix. Standard treatment consisted of pre-operative utero-vaginal brachytherapy (60 Gy) using a mould technique followed by a colpo-hysterectomy and external iliac lymphadenectomy. Overall 5 year actuarial survival for the whole population was 87% and disease-free survival 85%. Loco-regional relapse occurred in 23 patients (5%). Of these, 12 were central pelvic failures, 8 regional failures and 3 combined central and regional failures. There were 36 systemic relapses (8%) of which 12 relapsed concurrently in the pelvis. Five year actuarial pelvic disease-free, disease-free and overall survival was 87, 85 and 87%, respectively, for the whole population. 340 patients developed one or more complications [Grade 1: 198/441 (44%), Grade 2: 121/441 (27%) and Grade 3 or 4: 21/441 (4.7%)]. Five year actuarial survival for the whole population was poorer for histologically node positive than for node negative (89 vs. 55%, p less than 0.0001). Pre-operative brachytherapy followed by surgery can provide good local control with acceptable morbidity in early cervical cancer.

Entities:  

Mesh:

Year:  1992        PMID: 1546191     DOI: 10.1016/0167-8140(92)90337-t

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

Review 1.  [Ureteral stricture as a late complication of radiotherapy : Possible treatment options].

Authors:  J Kranz; A S Brandt; P Anheuser; B Reisch; J Steffens; S Roth
Journal:  Urologe A       Date:  2017-03       Impact factor: 0.639

2.  Adjuvant chemoradiation after laparoscopically assisted vaginal radical hysterectomy (LARVH) in patients with cervical cancer: oncologic outcome and morbidity.

Authors:  Arne Gruen; Thabea Musik; Christhardt Köhler; Jürgen Füller; Thomas Wendt; Carmen Stromberger; Volker Budach; Achim Schneider; Simone Marnitz
Journal:  Strahlenther Onkol       Date:  2011-05-16       Impact factor: 3.621

3.  Pathologic complete remission after preoperative high-dose-rate brachytherapy in patients with operable cervical cancer: preliminary results of a prospective randomized multicenter study.

Authors:  Julia Vízkeleti; Ildikó Vereczkey; Georgina Fröhlich; Szilvia Varga; Katalin Horváth; Tamás Pulay; Imre Pete; Csaba Nemeskéri; Árpád Mayer; Norbert Sipos; Miklós Kásler; Csaba Polgár
Journal:  Pathol Oncol Res       Date:  2014-07-11       Impact factor: 3.201

4.  Adjuvant radiotherapy after radical hysterectomy of the cervical cancer. Prognostic factors and complications.

Authors:  M Chatani; T Nose; N Masaki; T Inoue
Journal:  Strahlenther Onkol       Date:  1998-10       Impact factor: 3.621

5.  Pre-operative high-dose-rate brachytherapy in early-stage cervical cancer: long-term single-center results.

Authors:  Sylwia Kellas-Ślęczka; Piotr Wojcieszek; Marta Szlag; Magdalena Stankiewicz; Agnieszka Cholewka; Maciej Ślęczka; Agnieszka Badora-Rybicka; Piotr Lelek; Agnieszka Pruefer; Tomasz Krzysztofiak; Zofia Kołosza; Marek Fijałkowski
Journal:  J Contemp Brachytherapy       Date:  2022-01-19

Review 6.  External and internal triggers of cell death in yeast.

Authors:  Claudio Falcone; Cristina Mazzoni
Journal:  Cell Mol Life Sci       Date:  2016-04-05       Impact factor: 9.261

7.  Factors predicting parametrial invasion in patients with early-stage cervical carcinomas.

Authors:  Heng-Cheng Hsu; Yi-Jou Tai; Yu-Li Chen; Ying-Cheng Chiang; Chi-An Chen; Wen-Fang Cheng
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.